ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Investigational New Drug Application

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Health Care Economics and Organizations ∟ Social Control, Formal ∟ Legislation ∟ Legislation, Drug ∟ Drug and Narcotic Control ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Health Care Economics and Organizations ∟ Social Control, Formal ∟ Legislation, Drug ∟ Drug and Narcotic Control ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Health Care Quality, Access, and Evaluation ∟ Quality of Health Care ∟ Health Care Evaluation Mechanisms ∟ Evaluation Studies ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Health Services Administration ∟ Organization and Administration ∟ Pharmacy Administration ∟ Drug and Narcotic Control ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Health Services Administration ∟ Quality of Health Care ∟ Health Care Evaluation Mechanisms ∟ Evaluation Studies ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Investigative Techniques ∟ Evaluation Studies ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Social Sciences ∟ Sociology ∟ Social Control, Formal ∟ Legislation ∟ Legislation, Drug ∟ Drug and Narcotic Control ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Social Sciences ∟ Sociology ∟ Social Control, Formal ∟ Legislation, Drug ∟ Drug and Narcotic Control ∟ Drug Approval ∟ Investigational New Drug Application X
Broader terms:	Medical Subject Headings (MeSH) ∟ Health Care Economics and Organizations ∟ Social Control, Formal ∟ Legislation ∟ Legislation, Drug ∟ Drug and Narcotic Control ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Health Care Economics and Organizations ∟ Social Control, Formal ∟ Legislation, Drug ∟ Drug and Narcotic Control ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Health Care Quality, Access, and Evaluation ∟ Quality of Health Care ∟ Health Care Evaluation Mechanisms ∟ Evaluation Studies ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Health Services Administration ∟ Organization and Administration ∟ Pharmacy Administration ∟ Drug and Narcotic Control ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Health Services Administration ∟ Quality of Health Care ∟ Health Care Evaluation Mechanisms ∟ Evaluation Studies ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Investigative Techniques ∟ Evaluation Studies ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Social Sciences ∟ Sociology ∟ Social Control, Formal ∟ Legislation ∟ Legislation, Drug ∟ Drug and Narcotic Control ∟ Drug Approval ∟ Investigational New Drug Application Medical Subject Headings (MeSH) ∟ Social Sciences ∟ Sociology ∟ Social Control, Formal ∟ Legislation, Drug ∟ Drug and Narcotic Control ∟ Drug Approval ∟ Investigational New Drug Application Drug Approval > Drug and Narcotic Control > Legislation, Drug > Legislation > Social Control, Formal > Health Care Economics and Organizations > Medical Subject Headings (MeSH) Drug Approval > Drug and Narcotic Control > Legislation, Drug > Social Control, Formal > Health Care Economics and Organizations > Medical Subject Headings (MeSH) Drug Approval > Evaluation Studies > Health Care Evaluation Mechanisms > Quality of Health Care > Health Care Quality, Access, and Evaluation > Medical Subject Headings (MeSH) Drug Approval > Drug and Narcotic Control > Pharmacy Administration > Organization and Administration > Health Services Administration > Medical Subject Headings (MeSH) Drug Approval > Evaluation Studies > Health Care Evaluation Mechanisms > Quality of Health Care > Health Services Administration > Medical Subject Headings (MeSH) Drug Approval > Evaluation Studies > Investigative Techniques > Medical Subject Headings (MeSH) Drug Approval > Drug and Narcotic Control > Legislation, Drug > Legislation > Social Control, Formal > Sociology > Social Sciences > Medical Subject Headings (MeSH) Drug Approval > Drug and Narcotic Control > Legislation, Drug > Social Control, Formal > Sociology > Social Sciences > Medical Subject Headings (MeSH) X
Annotation:	U.S. or foreign, but if U.S., new drug "must be submitted to the FDA" before study in humans; DF: IND APPLICATION X
History note:	Drugs, Investigational (1990-1992)X
historyNote*:	93 X
publicMeSHNote*:	93 X
Scope note:	An application that must be submitted to a regulatory agency (the FDA in the United States) before a drug can be studied in humans. This application includes results of previous experiments; how, where, and by whom the new studies will be conducted; the chemical structure of the compound; how it is thought to work in the body; any toxic effects found in animal studies; and how the compound is manufactured. (From the "New Medicines in Development" Series produced by the Pharmaceutical Manufacturers Association and published irregularly.) X
activeMeSHYear*:	1995 \| 1996 \| 1997 \| 1998 \| 1999 \| 2000 \| 2001 \| 2002 \| 2003 \| 2004 \| 2005 \| 2006 \| 2007X
dateCreated*:	1992-05-20X
dateEstablished*:	1993-01-01X
dateRevised*:	1994-04-11X
recordAuthorizer*:	PLSX
recordMaintainer*:	PXPX
recordOriginator*:	TPWX
Type:	Concept X
URI:	X
Labels and equivalent concepts:	Uuden lääkkeen tutkimusanomus (fi) Investigational New Drug Applications (en, replaced) X
Share:	X